ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank recognized for providing financing and advisory services to emerging growth companies worldwide, today announced that the upcoming 22nd Annual OC Growth Stock Conference will include a healthcare track featuring the management teams from over 100 healthcare companies. The invitation-only conference will be held March 15-17, 2010 at The Ritz Carlton, located at 1 Ritz Carlton Drive, Dana Point, California.

The Healthcare track will showcase leading biotechnology, pharmaceutical, medical devices/diagnostics and healthcare services companies. In addition to company management presentations, Q&A sessions and one-on-ones, the healthcare track will include two expert panels.

Panel 1 will examine reimbursement in the pharmaceutical/biotechnology sector. John Aforismo, R.Ph, one of the leading specialists in the field, will help generate investment ideas, discuss general trends for different therapeutic segments and evaluate the outlook for the top ten drug launches in 2010. The panel -- You built it, Will they pay for it? -- is scheduled for Monday, March 15, 2010 at 12:30 pm.

Panel 2 will address the race to develop antivirals to treat new worldwide epidemics as well as the increased prevalence of such viral diseases as hepatitis and HIV among others. The panel will identify leading companies that are pioneering new treatments; as the winners in this race could generate above average returns for investors. The panel -- Antivirals—New Solutions to Old Problems -- will be held Tuesday, March 16, 2010 at 7:00 am.

This represents the largest contingent of healthcare companies at a ROTH conference, according to Mark Tobin, ROTH Director of Research. “This is consistent with our initiative to meet the growing interest by investors in healthcare companies. We continue to expand our research coverage in the sector and have assembled an enviable team of healthcare analysts.”

“With over 100 presenting healthcare companies, this event illustrates ROTH's serious focus and renewed momentum in the Life Sciences sector,” added John Chambers, ROTH Managing Director and Head of Healthcare Investment Banking. “Since the beginning of 2010 our team has executed eight financings raising over $100 million and we expect our visibility to continue to increase following our conference,” he concluded.

The three-day, institutional investor conference will be the largest ROTH conference ever and will feature management presentations from over 350 small cap public companies. The broad spectrum of presenting companies will represent the following sectors: Healthcare, Media & Internet, Enterprise Software, Gaming, Semiconductors, Global Energy and Industrials and Retail & Consumer. In addition, there will also be a China Track with over 100 China-based companies represented.

This event is designed to provide investors with a unique opportunity to gain insight into small- and mid-cap growth companies and is expected to attract 2,500 attendees, including over 1,500 institutional investors. The conference is formatted to maximize investor/company interaction through a combination of company presentations, Q&A sessions, expert panels and management one-on-one meetings.

A partial list of supporting conference sponsors at time of this announcement includes:

PLATINUM: AFH Holding & Advisory; Deloitte; Friedman LLP; DLA Piper; Loeb & Loeb LLP; Lowenstein Sandler; Pillsbury Winthrop Shaw Pittman LLP, and Thomson Reuters.

GOLD: Bullivant, Houser, Bailey PC; Capital IQ; Dorsey & Whitney LLP ; K&L Gates; Rothstein Kass; The Piacente Group, Inc.; and Winston & Strawn LLP.

SILVER: Anslow & Jaclin; Avant Air, Inc.; Belmont Accounting & Bookkeeping Services, LLC; Bernstein & Pinchuck LLP; Bloomberg; Business Wire, a Berkshire Hathaway Company; CCG Investor Relations ; Goodwin Procter; Halter Financial Summit: Junior Achievement; KPMG, LLP; Lambert, Edwards & Associates; Mayer Hoffman McCann P.C.; Moss Adams, LLP; Nasdaq OMX; NYSE Euronext; PrivateRaise - A Dealflow Media Service; Samuel H. Wong & Co. LLP, CPAs; SingerLewak; Sichenzia Ross Friedman Ference LLP; Stradling, Yocca, Carlson & Rauth; Stroock; Toronto Stock Exchange; Vintage Filings; and Weinberg & Company, P.A.

BDO and Grant Thornton are Participant Sponsors.

For more information about this invitation-only event, please visit the conference website at:

www.roth.com or contact your ROTH representative at 800-933-6830.

Media inquiries and press credentials only— pressbox4event@aol.com

About Roth Capital Partners, LLC:

ROTH Capital Partners is a full service investment banking firm dedicated to the small-cap public market. Since its inception in 1984, ROTH has been an innovator in this space. ROTH has participated in underwriting IPOs for small-cap companies, has helped develop the PIPE financing structure, and more recently in underwriting offerings from shelf registration statements. ROTH was one of the first U.S. investment banks to focus on financing small-cap Chinese companies, and established a Representative Office in Shanghai in 2007.

ROTH's experience and capabilities in raising capital for public companies are the hallmarks of the firm. It has raised over $12.6 billion for public companies and completed approximately 160 merger, acquisition and advisory assignments. During 2009, ROTH assisted public companies in raising over $1.8 billion.

Visit the Roth Capital Partners website at www.roth.com. Member FINRA/SIPC.

List of Confirmed Presenting Companies for ROTH 22^nd Annual OC Growth Stock Conference, March 15-17, 2010.

*List as of February 22, 2010. Subject to change. Past Performance is not indicative of future returns. This is not an offer or solicitation of the securities herein.

Key Words:

Small-Cap Stocks
Micro-Cap Stocks
PIPEs
Media
Energy
Software
Industrials
Retail
Technology
Healthcare
Financial Services
Consumer Goods
China
Institutional Investor
Medical Devices
Spec Pharma
Pharmaceuticals
Generics
Drug Delivery
Biotechnology
Registered Direct